Replies to post #377937 on Innovation Pharmaceuticals Inc (IPIX)

[Barron4664]

I agree with you. However two questions need to be answered. Will the MSM even bother to cover B if trial results are good as IPIX has zero clout for anything and so can be ignored? Second, if B is covered by MSM, the coverage will first have to be approved by the “Trusted News Initiative” to make sure any coverage does not interfere with the vaccine narrative and that all participants cover the news in the same way. That is just the way it is these days as Corporate media has engaged in collusion. It will be interesting to see. My guess is any good news will be ignored completely unless the news involves a BP.

[sunspotter]

“Brilacidin - Tingly fingers and toes is about all I have read as to side effects at the dosage needed to combat Covid and for all other uses of it.”

Where does it say that “numbness and tingling “ is confined to the fingers and toes? I can’t find that specific detail in the study report.

You must also have missed the frequent reports of high blood pressure which have resulted in prior CV disease being an exclusion criterion in current studies of brilacidin.

The fact is that with 70% of brilacidin patients experiencing one or more adverse events, it’s clearly a pretty dirty drug.